Spondyloarthropathy

"SpA" redirects here. For the Italian type of company see S.A. (corporation).

Product highlight

High-Recovery Anion Exchange Membrane Chromatography for Lentiviral Vector Purification

High-Performance Sterilizing-Grade Filtration for Solvents and Oily Formulations

Advanced Virus Quantification for Real-Time Process Control

Spondyloarthropathies are a group of related inflammatory joint diseases associated with the MHC class I molecule HLA-B27. The term seronegative spondylarthropathy is used by medical practitioners because this set of conditions may mimic rheumatoid diseases such as rheumatoid arthritis, but serological (blood) tests are typically negative for rheumatoid factor (RhF).

Subgroups (with increased HLA-B27 frequency) are:

• ankylosing spondylitis Caucasians (AS, 92%),
• ankylosing spondylitis African-Americans (AS, 50%),
• reactive arthritis (Reiter's syndrome) (RS, 60-80%),
• enteropathic arthritis associated with inflammatory bowel disease (IBD, 60%),
• Psoriatic arthritis (60%),
• isolated acute anterior uveitis (AAU, iritis or iridocyclitis, 50%), and
• undifferentiated SpA (USpA, 20-25%).

Whipple disease and Behçet disease may also be linked to HLA-B27, as may undifferentiated spondyloarthropathy.